SC 13G Filing

Company

Emergent BioSolutions Inc.

Filed

May 19, 2014

Accession Number

0000919574-14-003506

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →